Lollar P, Parker C G
Department of Medicine, University of Vermont, Burlington 05405.
Biochemistry. 1989 Jan 24;28(2):666-74. doi: 10.1021/bi00428a038.
Factor VIII (fVIII) is synthesized as a single chain having a domainal sequence A1-A2-B-A3-C1-C2. Analysis of the proteolyic cleavage of fVIII by thrombin by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) identifies three fragments designated fVIIIA1, fVIIIA2, and fVIIIA3-C1-C2 with fragment(s) derived from the B domain being difficult to visualize. The appearance of these fragments is associated with the development of coagulant activity, but the activity is labile without further apparent proteolysis. In this study, porcine fVIII was reacted with thrombin until peak coagulant activity was obtained and then subjected to cation-exchange (Mono S) high-pressure liquid chromatography. Coagulant activity was recovered in a single peak that contained all three fragments and was stable for weeks at 20 degrees C in 0.65 M NaCl/0.01 M His-HCl/0.005 M CaCl2 at pH 6.0. Analytical ultracentrifugation of activated fVIII was done to test whether all three fragments were associated. The apparent molecular weight of activated fVIII from equilibrium sedimentation increased from 148,000 to 161,000 as the loading concentration was increased from 0.06 to 0.16 mg/mL. This agrees well with the summed apparent molecular weights of fVIIIA1, fVIIIA2, and fVIIIA3-C1-C2 calculated from SDS-PAGE analysis (148,000) or from the amino acid sequence of human fVIII (159,000). This establishes the major species in the preparation as a fVIIIA1/A2/A3-C1-C2 heterotrimer and additionally indicates either weak self-association of the trimer and/or incomplete association of the individual subunits to form the trimer. Velocity sedimentation of activated fViii revealed a single boundry (S020,w = 7.2 S).(ABSTRACT TRUNCATED AT 250 WORDS)
凝血因子VIII(fVIII)最初合成时为单链,具有A1 - A2 - B - A3 - C1 - C2的结构域序列。通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳(SDS - PAGE)分析凝血酶对fVIII的蛋白水解作用,鉴定出三个片段,分别命名为fVIIIA1、fVIIIA2和fVIIIA3 - C1 - C2,而源自B结构域的片段难以观察到。这些片段的出现与凝血活性的产生相关,但该活性不稳定,无需进一步明显的蛋白水解作用。在本研究中,将猪fVIII与凝血酶反应直至获得峰值凝血活性,然后进行阳离子交换(Mono S)高压液相色谱分析。凝血活性在一个单一峰中回收,该峰包含所有三个片段,并且在20℃下于pH 6.0的0.65 M NaCl/0.01 M组氨酸 - 盐酸盐/0.005 M氯化钙中可稳定数周。对活化的fVIII进行分析超速离心,以测试所有三个片段是否相互关联。随着加载浓度从0.06增加到0.16 mg/mL,平衡沉降法测得的活化fVIII的表观分子量从148,000增加到161,000。这与通过SDS - PAGE分析计算出的fVIIIA1、fVIIIA2和fVIIIA3 - C1 - C2的表观分子量总和(148,000)或人fVIII的氨基酸序列计算出的结果(159,000)非常吻合。这确定了制剂中的主要种类为fVIIIA1/A2/A3 - C1 - C2异源三聚体,此外还表明三聚体存在弱的自缔合和/或单个亚基形成三聚体的不完全缔合。活化的fVIII的速度沉降显示出一个单一边界(S020,w = 7.2 S)。(摘要截短至250字)